Glycophorin A Protein, Mouse, Recombinant (His)

Glycophorin A Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 12.4 kDa and the accession number is P14220.

Glycophorin A Protein, Mouse, Recombinant (His)

パッケージサイズ	在庫状況	単価(税別)
100 μg	約5 days	￥ 96,000
500 μg	約5 days	￥ 383,500
1 mg	約5 days	￥ 643,000

バルクのお問い合わせ

説明	Glycophorin A Protein, Mouse, Recombinant (His) is expressed in HEK293 mammalian cells with C-His tag. The predicted molecular weight is 12.4 kDa and the accession number is P14220.

Species	Mouse
Expression Host	HEK293 Cells
Tag	C-His
Accession Number	P14220
別名	MNS, CD235a, HGpMiIII, MN, Glycophorin A, GpMiIII, GPSAT, PAS-2, HGpMiX, GPA, GYPA, Glycophorin-A, HGpMiV, HGpSta(C), HGpMiXI, GPErik
Construction	Met1-Val108
Protein Purity	> 95% as determined by Tris-Bis PAGE
分子量	The protein has a predicted MW of 12.4 kDa. Due to glycosylation, the protein migrates to 47-55 kDa based on Tris-Bis PAGE result.

Endotoxin	< 1 EU/μg by the LAL method.
Formulation	Lyophilized from a solution filtered through a 0.22 μm filter, containing PBS (pH 7.4). Typically, 8% trehalose is incorporated as a protective agent before lyophilization.
Reconstitution	Reconstitute the lyophilized protein in distilled water. The product concentration should not be less than 100 μg/ml. Before opening, centrifuge the tube to collect powder at the bottom. After adding the reconstitution buffer, avoid vortexing or pipetting for mixing.
Stability & Storage	It is recommended to store recombinant proteins at -20°C to -80°C for future use. Lyophilized powders can be stably stored for over 12 months, while liquid products can be stored for 6-12 months at-80℃. For reconstituted proteinsolutions, the solution can be stored at -20°c to -80'c for at least 3 months. Please avoid multiple freeze-thaw cycles and store products in aliquots.
Shipping	In general, Lyophilized powders are shipping with blue ice.
Research Background	Granulomatosis with polyangiitis (GPA) presents a wide spectrum of manifestations from the common respiratory symptoms to infrequent neurological and cardiac complications. The challenge in diagnosis and management makes the rapidly progressive disorder one of the most challenging dilemmas in clinical medicine.The ultimate goal is an improved prognosis through outcome measures which assesses the disease control with minimal adverse effects of intensive immunosuppressive regimens, an integral part of the clinical approach to improve the quality of life of GPA patients.

参考文献

1. Grygiel-Górniak B, et al. Clinical manifestations of granulomatosis with polyangiitis: key considerations and major features. Postgrad Med. 2018 Sep;130(7):581-596. doi: 10.1080/00325481.2018.1503920. Epub 2018 Aug 2. PMID: 30071173.

Calculator

Reconstitution Calculator

Recombinant Proteins Dilute Calculator

Specific Activity Calculator

bottom

Glycophorin A Protein, Mouse, Recombinant (His)

参考文献

Calculator

技術サポート

Keywords